Amgen Inc. Revenue 2007–2025
Amgen Inc. annual/quarterly revenue history and growth rate from 2007 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Amgen Inc. revenue for the quarter ending March 31, 2026 was 8.6 B, a 5.76% increase year-over-year.
- Amgen Inc. revenue for the twelve months ending March 31, 2026 was 35.5 B, a 13.64% increase year-over-year.
- Amgen Inc. annual revenue for 2025 was 36.8 B, a 9.95% increase from 2024.
- Amgen Inc. annual revenue for 2024 was 33.4 B, a 18.57% increase from 2023.
- Amgen Inc. annual revenue for 2023 was 28.2 B, a 7.09% increase from 2022.
- Amgen Inc. annual revenue for 2022 was 26.3 B.
Amgen Inc. (AMGN) — Frequently Asked Questions
Amgen Inc. (AMGN) is a publicly traded US company in the Healthcare sector. It has a market capitalization of $191.83B. In fiscal 2025 it reported revenue of $36.75B and net income of $7.71B. Explore AMGN's stock price, financial statements, earnings history, margins and key ratios below.
What is Amgen Inc.'s market cap?
Amgen Inc. (AMGN) has a market capitalization of $191.83B.
What is the AMGN stock price?
AMGN trades at $353.93 (+4.80% on the day).
How much revenue does Amgen Inc. make?
Amgen Inc. reported revenue of $36.75B in fiscal 2025.
Is AMGN profitable?
In fiscal 2025, Amgen Inc. reported net income of $7.71B.
What is AMGN's P/E ratio?
Based on diluted EPS, AMGN has a price-to-earnings (P/E) ratio of about 24.9.